Okano L

Department of Training and Supervision, Lykos Therapeutics, Inc., Santa Cruz, CA, United States.

2 papers

ArticleMDMA

The conceptual framework for the therapeutic approach used in phase 3 trials of MDMA-assisted therapy for PTSD.

O'Donnell KC, Okano L, Alpert M +6

Europe PMC2024
ArticleMDMA

Therapeutic setting as an essential component of psychedelic research methodology: Reporting recommendations emerging from clinical trials of 3,4-methylenedioxymethamphetamine for post-traumatic stress disorder.

Okano L, Jones G, Deyo B +2

Europe PMC2022